We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-4.15%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.68B
AUM Growth
+$769M
(+84%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
49.48%
Top 10 Holdings %
Top 10 Hldgs %
8.16%
Holding
2,474
New
799
Increased
624
Reduced
373
Closed
629
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.65M |
| 2 |
NFINU
Netfin Acquisition Corp. Unit
NFINU
|
+$2.57M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.42M |
| 4 |
Humana
HUM
|
+$2.37M |
| 5 |
Cigna
CI
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JFKKU
8i Enterprises Acquisition Corp Unit
JFKKU
|
+$1.58M |
| 2 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$1.31M |
| 4 |
CHAC.U
Chardan Healthcare Acquisition Corp.
CHAC.U
|
+$1.27M |
| 5 |
Artisan Partners
APAM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.91% |
| 2 | Technology | 1.1% |
| 3 | Consumer Discretionary | 1.05% |
| 4 | Communication Services | 0.58% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
CALL
Cullen/Frost Bankers
CFR
$10.3B
| $1.54M | 0.09% |
17,400
+12,100
| +228% | +$1.07M |
|
302
CALL
Corpay
CPAY
$24.7B
| $1.52M | 0.09% |
5,300
-9,300
| -64% | -$2.7M |
|
303
CALL
Agios Pharmaceuticals
AGIO
$2.24B
| $1.52M | 0.09% |
46,800
+5,500
| +13% | +$228K |
|
|
SINA
304
DELISTED
Sina Corp
SINA
| $1.52M | 0.09% |
38,688
+32,988
| +579% | +$1.35M |
|
305
CALL
H&R Block
HRB
$5.38B
| $1.51M | 0.09% |
64,100
+56,100
| +701% | +$1.48M |
|
|
SSPKU
306
DELISTED
Silver Spike Acquisition Corp. Units
SSPKU
| $1.51M | 0.09% |
+150,000
| New | +$1.5M |
|
307
CALL
Citigroup
C
$222B
| $1.5M | 0.09% |
+21,700
| New | +$1.48M |
|
308
CALL
Labcorp
LH
$24.4B
| $1.5M | 0.09% |
+10,360
| New | +$1.51M |
|
309
CALL
Williams-Sonoma
WSM
$27.2B
| $1.49M | 0.09% |
+43,800
| New | +$1.45M |
|
|
CRC
310
CALL
DELISTED
California Resources Corporation
CRC
| $1.48M | 0.09% |
145,200
+138,600
| +2,100% | +$1.78M |
|
311
CALL
Darden Restaurants
DRI
$23.3B
| $1.48M | 0.09% |
12,500
-5,100
| -29% | -$622K |
|
|
FL
312
CALL
DELISTED
Foot Locker
FL
| $1.48M | 0.09% |
34,200
+28,000
| +452% | +$1.13M |
|
|
ESPR
313
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.47M | 0.09% |
40,100
+38,800
| +2,985% | +$1.54M |
|
314
CALL
Charles River Laboratories
CRL
$10.8B
| $1.46M | 0.09% |
11,000
-7,400
| -40% | -$992K |
|
315
CALL
Skyworks Solutions
SWKS
$9.26B
| $1.45M | 0.09% |
+18,300
| New | +$1.46M |
|
316
CALL
Align Technology
ALGN
$12.1B
| $1.45M | 0.09% |
+8,000
| New | +$1.66M |
|
317
CALL
NRG Energy
NRG
$29.2B
| $1.45M | 0.09% |
36,500
-20,300
| -36% | -$734K |
|
|
CBPO
318
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.44M | 0.09% |
12,600
-11,000
| -47% | -$1.09M |
|
|
LOGM
319
CALL
DELISTED
LogMein, Inc.
LOGM
| $1.44M | 0.09% |
20,300
-25,600
| -56% | -$1.83M |
|
320
CALL
MSCI
MSCI
$41.1B
| $1.44M | 0.09% |
+6,600
| New | +$1.53M |
|
321
CALL
PTC Therapeutics
PTCT
$6.36B
| $1.43M | 0.09% |
42,400
+38,000
| +864% | +$1.65M |
|
322
CALL
Franco-Nevada
FNV
$41.3B
| $1.43M | 0.09% |
15,700
+2,200
| +16% | +$202K |
|
323
CALL
W.W. Grainger
GWW
$65.2B
| $1.43M | 0.08% |
4,800
+900
| +23% | +$250K |
|
324
CALL
BioMarin Pharmaceuticals
BMRN
$11.8B
| $1.42M | 0.08% |
21,100
+6,100
| +41% | +$470K |
|
325
PUT
Neurocrine Biosciences
NBIX
$17.7B
| $1.41M | 0.08% |
15,600
+3,000
| +24% | +$280K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Walleye Capital held 2,474 positions worth $1.68B, up 84% from $910M the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Walleye Capital deployed $831M of net new capital in Q3 2019, opening 799 new positions and adding to 624 existing holdings. Its largest new stake was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 1.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Arqule Inc, an estimated $1.22M trimmed.
- Walleye Capital's largest Q3 2019 buy was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
- Walleye Capital added most to Abiomed Inc in Q3 2019, an estimated $2.42M increase.
- Walleye Capital's biggest Q3 2019 reduction was Arqule Inc, cutting an estimated $1.22M.
- Walleye Capital fully exited 8i Enterprises Acquisition Corp Unit in Q3 2019, selling an estimated $1.58M.
- Walleye Capital's ten largest holdings make up 8.2% of its $1.68B portfolio in Q3 2019.
- Walleye Capital opened 799 new positions and closed 629 in Q3 2019.
- Walleye Capital's portfolio value rose 84% quarter-over-quarter to $1.68B.
Based on Walleye Capital's 13F filing for Q3 2019, filed 14 Nov 2019.